Tranexamic Technologies Launches Commercial Product for Cold Sores

Co-Founders Frank Murdock and Paul Stewart have announced that their latest partnership venture SkinStasis Skin Care has initiated a crowdfunding campaign through WeFunder to support the growth of its groundbreaking NEXTLEAP™ cold sore care product. The company has created NEXTLEAP™ leveraging Tranexamic Acid to address cosmetic concerns associated with cold sores. With a large market demand evident from surveys indicating dissatisfaction with current solutions, SkinStasis aims to revolutionize cold sore treatment.